143 related articles for article (PubMed ID: 28809123)
1.
Workman AD; Glicksman JT; Parasher AK; Carey RM; Brooks SG; Kennedy DW; Nabavizadeh SA; Learned KO; Palmer JN; Adappa ND
Otolaryngol Head Neck Surg; 2017 Dec; 157(6):1068-1074. PubMed ID: 28809123
[TBL] [Abstract][Full Text] [Related]
2. Performance of whole-body
Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):847-855. PubMed ID: 30604061
[TBL] [Abstract][Full Text] [Related]
3. Endoscopy versus imaging: Analysis of surveillance methods in sinonasal malignancy.
Khalili S; Worrall DM; Brooks S; Morris SM; Farquhar D; Newman JG; Learned KO; Ahn PH; Craig J; Kennedy DW; O'Malley BW; Palmer JN; Adappa ND
Head Neck; 2016 Aug; 38(8):1229-33. PubMed ID: 27142811
[TBL] [Abstract][Full Text] [Related]
4. Appropriate timing of surveillance intervals with whole-body
Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
Eur J Radiol; 2019 Sep; 118():75-80. PubMed ID: 31439262
[TBL] [Abstract][Full Text] [Related]
5. Temporal patterns of
Schwartz JS; Brooks SG; Stubbs V; Ghosh A; Tajudeen BA; Khalili S; Palmer JN; Lee JY; Nabavizadeh SA; Learned KO; Adappa ND
Int Forum Allergy Rhinol; 2016 Dec; 6(12):1301-1307. PubMed ID: 27383662
[TBL] [Abstract][Full Text] [Related]
6. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
[TBL] [Abstract][Full Text] [Related]
7. Posttreatment surveillance for sinonasal malignancy.
Workman AD; Palmer JN; Adappa ND
Curr Opin Otolaryngol Head Neck Surg; 2017 Feb; 25(1):86-92. PubMed ID: 27846019
[TBL] [Abstract][Full Text] [Related]
8. Utility of 3-Month Surveillance F-18 FDG PET/CT in Surgically Resected Oral Squamous Cell Carcinoma.
Marquardt M; Anderson C; Ginader T; Parkhurst J; Pagedar N; Bayon R; Clamon G; Hoover A; Buatti J
Ann Otol Rhinol Laryngol; 2018 Mar; 127(3):185-191. PubMed ID: 29313371
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
10. In-line (18)F-fluorodeoxyglucose positron emission tomography with computed tomography (PET/CT) in patients with carcinoma of the sinus/nasal area and orbit.
Wild D; Eyrich GK; Ciernik IF; Stoeckli SJ; Schuknecht B; Goerres GW
J Craniomaxillofac Surg; 2006 Jan; 34(1):9-16. PubMed ID: 16343913
[TBL] [Abstract][Full Text] [Related]
11. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
[TBL] [Abstract][Full Text] [Related]
12. Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma.
Tan C; Barrington S; Rankin S; Landau D; Pilling J; Spicer J; Cane P; Lang-Lazdunski L
J Thorac Oncol; 2010 Mar; 5(3):385-8. PubMed ID: 20087231
[TBL] [Abstract][Full Text] [Related]
13. The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma.
Stahlie EHA; van der Hiel B; Stokkel MPM; Schrage YM; van Houdt WJ; Wouters MW; van Akkooi ACJ
J Surg Oncol; 2020 Dec; 122(7):1328-1336. PubMed ID: 32783266
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
15. 18-FDG-PET in the initial staging of sinonasal malignancy.
Ramakrishnan VR; Lee JY; O'Malley BW; Palmer JN; Chiu AG
Laryngoscope; 2013 Dec; 123(12):2962-6. PubMed ID: 23877974
[TBL] [Abstract][Full Text] [Related]
16. The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma.
Haerle SK; Soyka MB; Fischer DR; Murer K; Strobel K; Huber GF; Holzmann D
Eur Arch Otorhinolaryngol; 2012 Jan; 269(1):127-33. PubMed ID: 21713453
[TBL] [Abstract][Full Text] [Related]
17. Utility of first positron emission tomography-computed tomography scan as a prognostic tool following treatment of sinonasal and skull base malignancies.
Abu-Ghanem S; Yafit D; Ghanayem M; Abergel A; Yehuda M; Fliss DM
Head Neck; 2019 Mar; 41(3):701-706. PubMed ID: 30521131
[TBL] [Abstract][Full Text] [Related]
18. Recurrence Patterns and Efficacy of Surveillance Modalities for Sinonasal Malignancies.
Tzelnick S; Levin EG; Yacobi D; Mizrachi A; Popovtzer A; Soudry E
Am J Rhinol Allergy; 2022 Jul; 36(4):473-479. PubMed ID: 35238217
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient.
Lonneux M; Lawson G; Ide C; Bausart R; Remacle M; Pauwels S
Laryngoscope; 2000 Sep; 110(9):1493-7. PubMed ID: 10983949
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG-PET/CT in the surveillance of patients with lymphoma: detection of asymptomatic recurrences.
García Vicente AM; Bellón Guardia M; Soriano Castrejón A; Calle Primo C; Cordero García JM; Palomar Muñoz A; Pilkington Woll JP; Talavera Rubio MP; Hernández Ruiz B
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):22-7. PubMed ID: 21742419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
